Blood Cancer Journal Q1
Unclaimed
Springer Nature
United Kingdom
Blood Cancer Journal is a journal indexed in SJR in Hematology and Oncology with an H index of 85. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3690 €. The scope of the journal is focused on hematologic malignancies, blood cancer, immunology. It has an SJR impact factor of 5,139 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,139.
Blood Cancer Journal focuses its scope in these topics and keywords: patients, monoclonal, cell, risk, nk, groups, introduction, myelofibrosis, increased, impacted, ...
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -



Categories:
Hematology (Q1)
Oncology (Q1)
Price
3690 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
5,139
SJR Impact factor85
H Index220
Total Docs (Last Year)549
Total Docs (3 years)7019
Total Refs4328
Total Cites (3 years)308
Citable Docs (3 years)6.17
Cites/Doc (2 years)31.9
Ref/DocOther journals with similar parameters
Blood Q1
The Lancet Haematology Q1
Leukemia Q1
Experimental Hematology and Oncology Q1
American Journal of Hematology Q1
Compare this journals
Comments